PDCD1 and Carcinoma, Lewis Lung: Therefore, this study aimed to assess the antitumor properties of QRHXF and investigate its synergistic interaction with anti-programmed cell death protein 1 (anti-PD-1) therapy within the TME in mice with Lewis lung carcinoma (LLC).